Treatment for children with diabetes: Type 1 vs. 2

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The main focus of treating diabetes in children, both type 1 and 2, is normalizing their blood sugar levels to reduce risk of long-term complications.

Blood sugar levels are monitored by use of the hemoglobin A1c test, which allows doctors to estimate the average blood sugar level for the past three months.

Higher hemoglobin A1c readings are associated with diabetic complications. Therefore, doctors often set ideal A1c targets for their diabetic patients, as well as encourage well-balanced diets and exercise to help manage the condition.

Advancements in the treatment of type 1 diabetes are allowing children who are diagnosed with the disease to live much more normal and high quality lifestyles. Type 1 diabetics no longer have to adhere to extremely strict dietary regimens and schedules because insulin medications can now be adjusted to what and when you eat.

Most pediatric type 2 diabetic patients are treated with a combination of lifestyle modifications, including changes to diet and exercise habits, and medication. Glucophage, commonly known as metformin, is the only FDA-approved treatment for type 2 diabetes in children. This medication has been proven to help regulate blood sugar levels, and in some cases, help with weight loss.

Fortunately, our community has an exceptional team of pediatric endocrinologists and medical support staff at Cone Health Pediatric Sub-Specialists of Greensboro that is dedicated to educating children and families about diabetes and providing exceptional treatment for children with the condition here in our community.

Spokesperson Background:

Dr. Jennifer Badik is a pediatric endocrinologist at Cone Health Pediatric Sub-Specialists of Greensboro.  Dr. Badik earned her Doctor of Medicine at Temple University in 2006.  She completed her residency in pediatrics at University of Arizona in 2009, and completed a fellowship in pediatric endocrinology and diabetes at Emory University in 2012.